1-26282374-ACC-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PVS1_ModerateBA1
The NM_001389556.1(UBXN11):c.1486_1487delGG(p.Gly496fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.268 in 601,844 control chromosomes in the GnomAD database, including 13,135 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.29 ( 2261 hom., cov: 0)
Exomes 𝑓: 0.26 ( 10874 hom. )
Consequence
UBXN11
NM_001389556.1 frameshift
NM_001389556.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.135
Genes affected
UBXN11 (HGNC:30600): (UBX domain protein 11) This gene encodes a protein with a divergent C-terminal UBX domain. The homologous protein in the rat interacts with members of the Rnd subfamily of Rho GTPases at the cell periphery through its C-terminal region. It also interacts with several heterotrimeric G proteins through their G-alpha subunits and promotes Rho GTPase activation. It is proposed to serve a bidirectional role in the promotion and inhibition of Rho activity through upstream signaling pathways. The 3' coding sequence of this gene contains a polymoprhic region of 24 nt tandem repeats. Several transcripts containing between 1.5 and five repeat units have been reported. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0493 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.389 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBXN11 | NM_001389556.1 | c.1486_1487delGG | p.Gly496fs | frameshift_variant | 15/15 | ENST00000374222.6 | NP_001376485.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBXN11 | ENST00000374222.6 | c.1486_1487delGG | p.Gly496fs | frameshift_variant | 15/15 | 5 | NM_001389556.1 | ENSP00000363339.1 |
Frequencies
GnomAD3 genomes AF: 0.287 AC: 22046AN: 76750Hom.: 2255 Cov.: 0
GnomAD3 genomes
AF:
AC:
22046
AN:
76750
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0435 AC: 4550AN: 104586Hom.: 618 AF XY: 0.0445 AC XY: 2552AN XY: 57410
GnomAD3 exomes
AF:
AC:
4550
AN:
104586
Hom.:
AF XY:
AC XY:
2552
AN XY:
57410
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.265 AC: 139082AN: 525038Hom.: 10874 AF XY: 0.268 AC XY: 69735AN XY: 260558
GnomAD4 exome
AF:
AC:
139082
AN:
525038
Hom.:
AF XY:
AC XY:
69735
AN XY:
260558
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.287 AC: 22060AN: 76806Hom.: 2261 Cov.: 0 AF XY: 0.294 AC XY: 11035AN XY: 37484
GnomAD4 genome
AF:
AC:
22060
AN:
76806
Hom.:
Cov.:
0
AF XY:
AC XY:
11035
AN XY:
37484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Small cell lung carcinoma Pathogenic:1
Pathogenic, no assertion criteria provided | research | Arun Kumar Laboratory, Indian Institute of Science | Jun 15, 2021 | - - |
Lung cancer Pathogenic:1
Pathogenic, no assertion criteria provided | research | Arun Kumar Laboratory, Indian Institute of Science | Jun 15, 2021 | - - |
Hepatocellular carcinoma Pathogenic:1
Pathogenic, no assertion criteria provided | research | Arun Kumar Laboratory, Indian Institute of Science | Jun 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at